Progress in hepatectomy for hepatocellular carcinoma and peri-operation management

被引:13
作者
Chen, Hao [1 ,2 ]
Jia, Weidong [1 ,2 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Hepat Surg, Div Life Sci & Med, Hefei 230001, Anhui, Peoples R China
[2] Anhui Prov Key Lab Hepatopancreatobiliary Surg, Hefei 230001, Anhui, Peoples R China
关键词
Enhanced recovery after surgery; Hepatectomy; Hepatocettutar carcinoma; Precision medicine; Treatment; INTERMITTENT PRINGLE MANEUVER; RANDOMIZED-CLINICAL-TRIAL; LIVER-FUNCTION TESTS; OF-THE-ART; INDOCYANINE GREEN; HEPATIC RESECTION; INITIAL-EXPERIENCE; ENHANCED RECOVERY; HARMONIC SCALPEL; PD-1; BLOCKADE;
D O I
10.1016/j.gendis.2020.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient management approaches, including enhanced recovery after surgery, targeted therapy, and immunotherapy. We compare traditional and innovative management methods, which comprise developments in precision medicine, and consider their limitations. Ongoing innovation and technological advances enable surgeons to gain deeper understandings of the multidimensionality of hepatocellular carcinoma, thereby promoting the continuous development of precision therapy. Copyright (C) 2020, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 89 条
[11]   Personalized therapy for hepatocellular carcinoma: Where are we now? [J].
Chan, Stephen L. ;
Wong, Alissa M. ;
Lee, Kirsty ;
Wong, Nathalie ;
Chan, Allen K. C. .
CANCER TREATMENT REVIEWS, 2016, 45 :77-86
[12]   Robotic resections in hepatobiliary oncology - initial experience with Xi da Vinci system in India [J].
Chandarana, M. ;
Patkar, S. ;
Tamhankar, A. ;
Garg, S. ;
Bhandare, M. ;
Goel, M. .
INDIAN JOURNAL OF CANCER, 2017, 54 (01) :52-+
[13]   The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma [J].
Chuma, Makoto ;
Hige, Shuhei ;
Kamiyama, Toshiya ;
Meguro, Takashi ;
Nagasaka, Atsushi ;
Nakanishi, Kazuaki ;
Yamamoto, Yoshiya ;
Nakanishi, Mitsuru ;
Kohara, Toshihisa ;
Sho, Takuya ;
Yamamoto, Keiko ;
Horimoto, Hiromasa ;
Kobayashi, Tomoe ;
Yokoo, Hideki ;
Matsushita, Michiaki ;
Todo, Satoru ;
Asaka, Masahiro .
JOURNAL OF GASTROENTEROLOGY, 2009, 44 (09) :991-999
[14]   A New Initiative on Precision Medicine [J].
Collins, Francis S. ;
Varmus, Harold .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) :793-795
[15]   Nuclear Imaging Techniques for the Assessment of Hepatic Function in Liver Surgery and Transplantation [J].
de Graaf, Wilmar ;
Bennink, Roelof J. ;
Vetelainen, Reeta ;
van Gulik, Thomas M. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (05) :742-752
[16]   Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial [J].
El-Khoueiry, Anthony B. ;
Sangro, Bruno ;
Yau, Thomas ;
Crocenzi, Todd S. ;
Kudo, Masatoshi ;
Hsu, Chiun ;
Kim, Tae-You ;
Choo, Su-Pin ;
Trojan, Jorg ;
Welling, Theodore H., III ;
Meyer, Tim ;
Kang, Yoon-Koo ;
Yeo, Winnie ;
Chopra, Akhil ;
Anderson, Jeffrey ;
dela Cruz, Christine ;
Lang, Lixin ;
Neely, Jaclyn ;
Tang, Hao ;
Dastani, Homa B. ;
Melero, Ignacio .
LANCET, 2017, 389 (10088) :2492-2502
[17]   How to do a combined robotic anterior resection and liver resection: da Vinci Xi [J].
Eu, Ernest W. ;
Ngu, James C. ;
Chiow, Adrian K. H. .
ANZ JOURNAL OF SURGERY, 2018, 88 (10) :1076-1077
[18]  
Fan ST, 2007, HEPATOB PANCREAT DIS, V6, P430
[19]  
Feliciano DV, 2017, AM SURGEON, V83, P1193
[20]   Part I: Liver function in oncology: biochemistry and beyond [J].
Field, Kathryn M. ;
Dow, Chris ;
Michael, Michael .
LANCET ONCOLOGY, 2008, 9 (11) :1092-1101